Morning Overview on MSN
New drugs target senescent "zombie" cells, opening a cancer pathway
Chemotherapy kills cancer cells, but it also leaves behind something troubling: damaged cells that stop dividing yet refuse ...
Rushika M. Perera, the Deborah Cowan Professor and vice chair of the Department of Anatomy, and chief scientific officer of ...
4d
Dual-pathway blockade therapy offers hope for rare, hard-to-treat gynecological clear cell cancers
Before her cancer diagnosis in early 2017, 48-year-old Caitlin Delaney, who is based in Australia, had been struggling with a ...
13hon MSN
Turning immune cells into tumor allies: A cancer cell protein can reprogram frontline defenders
Cancer cells can disarm the immune system not just by hiding from it, but by actively reprogramming nearby immune cells into ...
Innovative Directions in Esophagogastric Cancer Care: from Single-center to Real-World EvidenceEsophageal and gastric cancers remain among the most lethal ...
Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual ...
The investigational agent IMNN-001 is demonstrating promising potential to extend survival in patients with advanced ovarian ...
EVANSVILLE, Ind. (WEHT) — A local nonprofit supporting those impacted by cancer is being recognized while also expanding its reach in the community. Cancer Pathways Midwest has been named the March ...
Scientists assumed that one specific immune cell subtype was required for mRNA vaccination to activate the immune system. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results